Premium
Randomized trials and quality assurance in gastric cancer surgery
Author(s) -
Dikken Johan L.,
Cats Annemieke,
Verheij Marcel,
van de Velde Cornelis J.H.
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23080
Subject(s) - medicine , quality assurance , referral , cancer , cancer surgery , audit , lymphadenectomy , randomized controlled trial , chemoradiotherapy , clinical trial , general surgery , perioperative , surgery , family medicine , external quality assessment , management , pathology , economics
A D2 lymphadenectomy can be considered standard of surgical care for advanced resectable gastric cancer. Currently, several multimodality strategies are used, including postoperative monochemotherapy in Asia, postoperative chemoradiotherapy in the United States, and perioperative chemotherapy in Europe. As the majority of gastric cancer patients are treated outside the framework of clinical trials, quality assurance programs, including referral to high‐volume centers and clinical auditing are needed to improve gastric cancer care on a nationwide level. J. Surg. Oncol. 2013;107:298–305. © 2012 Wiley Periodicals, Inc.